Prevalence and healthcare costs associated with the management of diabetic foot ulcer in patients attending Ahmadu Bello University Teaching Hospital, Nigeria

Authors

  • Umar Mukhtar Danmusa Faculty of Pharmaceutical Sciences Usmanu Danfodiyo University, Sokoto Sokoto State
  • Iorliam Terhile Department of Pharmaceutical Services Ahmadu Bello University Teaching Hospital Shika 06, Kaduna State
  • Idris Abdullahi Nasir Department of Medical Laboratory Services University of Abuja Teaching Hospital PMB 228 Gwagwalada, FCT Abuja,
  • Auwal Alkasim Ahmad Faculty of Pharmacy Ahmadu Bello University PMB 05 Zaria, Kaduna state
  • Habiba Yahaya Muhammad Department of Chemical Pathology Aminu Kano Teaching Hospital PMB 3452 Zaria road Kano state.

Keywords:

Diabetic mellitus, Diabetic foot ulcer, financial costs, chemotherapy, Nigeria

Abstract

Introduction: Diabetic foot ulcers (DFU) are non-traumatic lesions of the skin on feet of diabetic patients. DFU require appropriate investigations, dietary placement and clinical management. These constitute huge healthcare costs in DFU care.

Objective: This study sought to determine the prevalence of DFU in relation to clinical, sociodemographic variables and healthcare costs expended.

Methods: This was a retrospective study. Hence, medical records and healthcare costs of 1573 DFU-diagnosed patients who visited the diabetic clinic and medical wards of Ahmadu Bello University Teaching Hospital, Nigeria were reviewed and analyzed for relevant data.

Results: The prevalence of DFU in patients with diabetic mellitus (DM) was 6.0% with more cases in men (67.2%) than women (32.8%). The prevalence of DFU in relation to type of DM was 6.5% and 0% for DM type-II and DM type-I respectively. The distribution of DFU in relation to clinical stages was 40%, 25.7%, 17.1% and 11.4% for stages-IV, III, II and I. Patients in the age group 51-60 years had the highest frequency of DFU (28.6%), but there was no DFU in those 10-20 years and > 80 years. It required an average of 1808 US$ to successfully treat patients with DFU stage IV, while 1104 US$ and 556 US$ was required to treat DFU stage III and II respectively. Cost of procuring drugs covered the highest burden of total healthcare cost in managing DFU (35%-46%).

Conclusion: The prevalence of DFU in DM patients attending ABUTH was high. Healthcare costs associated with DFU especially cost of drugs procurement contributed the highest financial burden in managing DFU.

Keywords: Diabetic mellitus, Diabetic foot ulcer, Financial costs, Chemotherapy, Nigeria.

Author Biographies

Umar Mukhtar Danmusa, Faculty of Pharmaceutical Sciences Usmanu Danfodiyo University, Sokoto Sokoto State

Pharmacist

Iorliam Terhile, Department of Pharmaceutical Services Ahmadu Bello University Teaching Hospital Shika 06, Kaduna State

Chief Pharmacist

Idris Abdullahi Nasir, Department of Medical Laboratory Services University of Abuja Teaching Hospital PMB 228 Gwagwalada, FCT Abuja,

Medical Laboratory Scientist

Auwal Alkasim Ahmad, Faculty of Pharmacy Ahmadu Bello University PMB 05 Zaria, Kaduna state

Pharmacist

Habiba Yahaya Muhammad, Department of Chemical Pathology Aminu Kano Teaching Hospital PMB 3452 Zaria road Kano state.

Medical Laboratory Scientist

Downloads

Published

2016-03-23

How to Cite

Danmusa, U. M., Terhile, I., Nasir, I. A., Ahmad, A. A., & Muhammad, H. Y. (2016). Prevalence and healthcare costs associated with the management of diabetic foot ulcer in patients attending Ahmadu Bello University Teaching Hospital, Nigeria. International Journal of Health Sciences, 10(2). Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/1358

Issue

Vol. 10 No. 2 (2016)

Section

Original Paper

License


Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).